Stay ConnectedWelcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge.
Contact us: psychroundspodcast@gmail.com
Instagram: https://www.instagram.com/psychrounds/
Copyright: © Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails.
Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract’
One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1
SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720
On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network.
References:
On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies.
Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/
Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network.
References
Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).
On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.
https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/
https://pubmed.ncbi.nlm.nih.gov/34108247/
https://pubmed.ncbi.nlm.nih.gov/25577164/
In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry (learn more).
https://x.com/jd_rosenblat?lang=en
https://pubmed.ncbi.nlm.nih.gov/35688035/
https://pubmed.ncbi.nlm.nih.gov/39608193/
Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.
Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.
Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.
Our TOPPODCAST Picks 
